CytoDel
2012
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Angel
LATEST DEAL TYPE
$3.9M
LATEST DEAL AMOUNT
3
INVESTORS
Description
Provider of a biotechnology platform intended to produce recombinant derivatives of botulinum neurotoxin. The company's biotechnology platform manipulates the BONT molecule into a drug delivery vehicle that can deliver therapeutic molecules to the inside of neurons with important implications, enabling medical researchers to develop drugs and facilitate the treatment of nervous system disorders, chronic pain and neuro-degenerative diseases.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 423 West 127th Street
- New York, NY
- United States
+1 (646) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore CytoDel’s full profile, request a free trial.
CytoDel Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Angel (individual) | 16-Jan-2018 | $3.9M | 00.00 | Completed | Startup | |
| 3. Grant | 01-Jul-2017 | 000.00 | Completed | Startup | ||
| 2. Grant | 01-Jan-2014 | $224K | Completed | Startup | ||
| 1. Accelerator/Incubator | 13-Dec-2013 | Completed | Startup |
CytoDel Competitors (6)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Amgen | Formerly PE-Backed | Thousand Oaks, CA | 00000 | 00.000 | 000000000000 | 00.000 |
| 000000 | Formerly VC-backed | Cambridge, MA | 0000 | 000.00 | 00000000000 | 000.00 |
| 000 00000 | Corporation | Indianapolis, IN | 00000 | 000000 - 000 | ||
| 0000 000000 | Corporation | Frankfurt, Germany | 0000 | |||
| 00000000 | Corporate Backed or Acquired | Dublin, Ireland | 0000 | 000000&0 |
CytoDel Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| National Institutes of Health | Government | 000 0000 | 000000 0 | |||
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | |||
| NYU Innovation Venture Fund | Venture Capital | Minority | 000 0000 | 000000 0 |
CytoDel Executive Team (3)
CytoDel Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Philip Band Ph.D | CytoDel | Co-Founder, Co-Inventor, Chief Executive Officer & Board Member | 000 0000 |